Welcome!

Java Authors: Yeshim Deniz, Pat Romanski, Liz McMillan, Adrian Bridgwater, Sharon Barkai

News Feed Item

The University of Texas MD Anderson Cancer Center Selects Oracle Applications and Technology as Part of Platform to Help Transform Cancer Care

Oracle Solutions to Create Foundation for Analytical Initiative Designed to Advance Personalized Cancer Care and Improve Outcomes While Optimizing Operational Efficiency

REDWOOD SHORES, CA -- (Marketwire) -- 01/31/13 -- Oracle (NASDAQ: ORCL)

News Facts

  • MD Anderson, one of the world's most respected centers devoted exclusively to cancer patient care, research, education and prevention, has selected Oracle Health Sciences applications and Oracle technology as the foundation for an organization-wide analytics initiative designed to enable a new generation of personalized cancer treatment that improves outcomes. The platform will also support the center's renowned Moon Shots Program, an unprecedented effort to dramatically accelerate the pace of converting scientific discoveries into clinical advances that reduce cancer deaths.
  • Oracle applications and technology will power the enterprise analytics initiative, one of the program's platforms. The new platform will bring together clinical, genomic, financial, administrative and operational information from internal and external sources to yield insights that drive care innovation and optimize operational efficiency.
  • To achieve its goals, the center, ranked first for cancer care in U.S. News & World Report's "Best Hospitals" survey for seven of the last nine years, will deploy a wide range of Oracle solutions, including Oracle Enterprise Healthcare Analytics and Oracle Translational Research Center
  • MD Anderson, which sees data growth of 30 percent to 40 percent annually, is also deploying Oracle Database and Oracle Business Intelligence Enterprise Edition.

Supporting Quotes

  • "MD Anderson, in its quest to continuously improve cancer care outcomes and quality of life for patients, has built a culture of innovation that consistently delivers life-changing gains for cancer patients. As we focus on the next-generation of treatments -- including our Moon Shots Program -- we require a powerful analytical infrastructure that can yield new insight from the unprecedented volume of data available today. Oracle's integrated health sciences applications, enterprise applications and technology stack will help provide one of the robust foundations that we need to accelerate deployment, and ultimately, discovery of life-saving treatments," said Dr. John Frenzel, chief medical information officer, MD Anderson.
  • "Leveraging data and information to drive more effective resource utilization, improve operational efficiency, and level patient volumes across the days of the week is becoming increasingly more important. Through the use of Oracle Enterprise Healthcare Analytics, we are creating the platform to improve delivery of actionable information to our customers so they can effectively improve processes," said Craig Owen, director of clinical analytics and informatics, MD Anderson.
  • "MD Anderson is recognized globally for its ground-breaking research and life-saving advances in cancer care. Its next generation analytics initiative, built on industry-leading platforms like Oracle Enterprise Healthcare Analytics and Oracle technology, stands to further amplify healthcare insight and accelerate innovation," said Neil de Crescenzo, senior vice president and general manager, Oracle Health Sciences. "We are honored to be a part of this important initiative and to be working with such a world leader in oncology research and care."

Supporting Resources

About Oracle
Oracle engineers hardware and software to work together in the cloud and in your data center. For more information about Oracle (NASDAQ: ORCL), visit www.oracle.com.

About Oracle in Industries
Oracle industry solutions leverage the company's best-in-class portfolio of products to address complex business processes relevant to health sciences, helping speed time to market, reduce costs, and gain a competitive edge.

Trademarks
Oracle and Java are registered trademarks of Oracle and/or its affiliates. Other names may be trademarks of their respective owners.

Contact Info

Greg Lunsford
Oracle
+1.650.506.6523
Email Contact

Mary Tobin
O'Keeffe & Company
+1.503.658.7396
Email Contact

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.